Moderate alcohol consumption is associated with increased insulin sensitivity and a reduced risk for type 2 diabetes. An important endogenous mediator of insulin sensitivity is adiponectin (AN), an adipokine that displays numerous antiatherogenic, antidiabetogenic and antiinflammatory effects. Recently, acute increase in alcohol consumption has been shown to be associated with increase in plasma adiponectin and, concomitantly, insulin sensitivity. Whether chronic alcohol consumption predicts an increase in plasma AN and whether this is independent of adiposity, markers of liver dysfunction, and plasma adipokines such as tumor necrosis factor (TNF)-α is not known. We, therefore, investigated these relationships in 75 men who were diagnosed with liver steatosis using ultrasound/liver biopsy.
INTRODUCTION
Adiponectin (AN) is a protein secreted by adipose tissue which displays several antiatherogenic, antidiabetogenic and antiinflammatory effects. In target tissues, it is an antagonist of TNF-α [1] [2] [3] . AN inhibits the production of glucose in the liver, enhances lipoprotein clearance and increases beta oxidation of fatty acids [3] [4] [5] [6] [7] 13 .
Experimental and clinical studies have repeatedly confirmed that AN concentration shows a positive correlation with insulin sensitivity and a negative correlation with amount of adipose tissue. Low AN values have been associated with a high basal and reduced insulin-induced phosphorylation of tyroxin receptor for tyrosine kinase in muscle, resulting in progression of insulin resistance 8 .
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Low AN values typically occur in obese individuals, type 2 diabetic patients, persons with metabolic syndrome and persons with coronary artery disease (CAD). High AN values are associated with good insulin sensitivity, lower frequency of type 2 diabetes mellitus and CAD [9] [10] [11] [12] [13] [14] [15] [16] [17] . It has been confirmed that administration of recombinant AN to mice corrected hyperglycemia (reduction of liver gluconeogenesis), decreased insulin resistance and reduced plasma atherogenicity 3, 4, 9, 18 . AN also inhibits cell adhesion and neointimal formation in vessels, thus inhibiting the progression of atherosclerotic alterations 19 . Moderate alcohol consumption influences many metabolic parameters positively. It is known to be associated with higher HDL concentrations, lower atherogenic risk, lower oxidative stress and higher insulin sensitivity 20 . The effect of alcohol consumption on AN production and concentration in blood has not yet been investigated. At the time this paper was being prepared, two communications have been published. One was based on a mice experiment in which mice had been administered ethanol as a substantial component of caloric supply. This resulted in a significant decrease of AN in blood 21 . Another investigation made use of human volunteers who consumed alcohol for several weeks which resulted, in contrast to the mice experiment, in increased AN concentrations 20 . Alcohol consumption may cause liver steatosis. Both alcohol-induced (ASH) and non-alcoholic liver steatosis (NASH) are chronic liver diseases. Their incidence is increasing and is becoming a significant cause of mortality in developed countries. 21 NASH occurs mainly in individuals with metabolic syndrome; almost 20 % of affected individuals develop liver cirrhosis 22, 23 . The aim of the present study was to find relations between AN and long-term alcohol consumption with regard to TNF-α concentrations, insulin sensitivity and laboratory markers of liver injury in subjects with liver steatosis.
METHODS
We examined 75 men with liver steatosis diagnosed by sonography, increased laboratory markers and liver biopsy. The subjects filled in a questionnaire on frequency and quantity of alcohol intake. The study was approved by the ethical commission of the Hospital Šternberk.
The group under study was divided into two subgroups -drinkers and non-drinkers according to the following two criteria defined: a) mean alcohol intake > 40 g of alcohol daily for over 4 weeks versus absolute non-drinking for the same period b) CDT concentration (cut-off > 2.75 %)
If CDT values discriminated patients into the other group than the one they specified in the questionnaire (non-drinkers with CDT > 2.75 %, drinkers with CDT < 2.75 %), such individuals were excluded from the study.
Blood samples was drawn under aseptic precautions from vena cubiti, samples were centrifuged 10 min in comparison with non-drinkers suffering from similar hepatopathy 4 0 C with 3000 g and subsequently frozen at -80 0 C. All persons were examined for serum adiponectin concentration (Adiponectin, validated sandwich ELISA, Biovendor, Brno, The Czech Republic) with satisfying analytical characteristics (intrassay coefficient of variation (CV) = 5.4 %, interassay CV = 6.8 %), glucose (Glucose GOD-POD, Biovendor), triglycerides (Triglycerides, Biovendor), activity of ALT (ALT, Biovendor), AST (AST, Biovendor) and CDT % (Axis-Shield, Oslo, Norway), insulin (Insulin, DPC, USA, California, Los Angeles) and TNF-α (TNF-α, DPC, California, Los Angeles). Insulin and glycemia were taken for calculating the insulin sensitivity index (Quicki).
Body weight of patients was measured in their underwear, without any belongings (keys, shoes etc.).
Statistical data were processed by the Medcalc software (Medcalc, Mariakerke, Belgium).
RESULTS
Forty eight probands were classified as moderate drinkers, twenty seven as non-drinkers. Four subjects were excluded due to differences between anamnestic information on alcohol consumption and corresponding CDT % values (see Methods).
Normal distribution of all parameters was found in both subgroups (drinkers and non-drinkers).
Moderate drinkers had significantly higher serum adiponectin concentrations (mean 13.8 vs 9.1 mg/l) and adiponectin after correction to BMI compared to nondrinkers (0.5 vs 0.26). They also showed higher activities of AST, GMT as well as higher medium erythrocyte volume (MCV) compared to non-drinkers.
Other parameters did not differ significantly (Table 1 , Fig. 1, Fig. 2) . Dividing the cohort according to alcohol intake showed that a positive correlation between serum adiponectin with TNF-α (r = 0.6; p = 0.0001) and between serum AN and AST/ALT index (r = 0.34; p = 0.0295) was found in drinkers only. A negative correlation of AN with BMI was found in both drinkers (r = -0.42; p = 0.01) and non-drinkers (r = -0.61; p = 0.012) ( Table 3) .
In drinkers, AN/BMI index correlated positively with TNF-α concentration (r = 0.64; p = 0.041, Spearman), AST/ALT index (r = 0.72; p = 0.0005, Spearman) and negatively with triglycerides concentration (r = -0.55; p = 0.045, Spearman). Non-drinkers showed only a distinct negative correlation between glycemia and adiponectin (r = -0.72; p = 0.045, Spearman) ( Table 4) .
Drinkers revealed a positive correlation between CDT and TNF-α (r = 0,5; p = 0,041) and between CDT and AST (r = 0,43; p = 0,02). In non-drinkers, a significant negative correlation was found between TNF-α and the Quicki index of insulin sensitivity (r = -0.42; p = 0,032) ( Table 5) .
The stepwise variable regression showed that out of all measured parameters only the adiponectin value could be used to calculate the regression formula to assess drinkers (F 8.44; p = 0.0103, R 2 0.35) (of course, except for CDT % which was used for defining this subgroup).
The values of AN/BMI index > 0.19 had 100 % sensitivity and 63 % specificity for identifying drinkers (Fig. 6) .
To illustrate the diagnostic validity of AN/BMI for identifying drinkers, the ROC curves for adiponectin/ BMI were compared with GMT and Mean Erythrocyte (Corpuscular) Volume (MCV). The resulting Areas Under Curve (AUC) did not differ significantly and all three were of diagnostic value (AUC for adiponectin/BMI was 0.89 (95% CI 0.67-0.96), AUC for GMT was 0.81 (95 % CI 0.61-0.93) and AUC for MCV was 0.84 (95% CI 0.64-0.93) (Fig. 7) .
DISCUSSION
Liver steatosis is characterized by overproduction of inflammatory cytokines (TNF-α, Interleukin-1β a Interleukin-6) by activated Kupffer cells and by imbalance of the production of inflammatory and anti-inflammatory cytokines in the liver [24] [25] [26] [27] reducing adiponectin expression in adipose tissue 28, 29 . Anti-inflammatory cytokines have hepatoprotective effect 27 . Decreased concentration of Interleukin-10 in mice model after alcohol intake or its absence in Interleukin-10 knockout mice leads to a markedly enhanced incidence of hepatic necrosis 30 .
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The alcohol-induced hepatic involvement is also markedly reduced by administration of antibodies against TNF-α 31 and completely eliminated in TNF-α receptor 1 knock-out mice model 32 . In addition, therapy with thalidomid (inhibitor of TNF-α production in Kupffer cells) inhibits alcohol-induced liver injury 11 . High concentrations of TNF-α lead to high basal phosphorylation of muscle insulin receptor and is manifested as insulin resistance 34, 35 . In general, AN and TNF-α are antagonist proteins. TNF-α is considered a causal factor of insulin resistance. By contrast, AN enhances insulin sensitivity 2, 3 . AN displays antiatherogenic effects 36, 37 , TNF-α leads to progression of atherosclerosis 33, 38 . One experimental study showed that administration of AN resulted in decreased production of TNF-α by the liver and reduced concentration of TNF-α in circulation 39 . These findings were also confirmed in adiponectin-knockout mice models, where high expression and production of TNF-α were demonstrated 4 .
Enhanced expression of cytokines and chemokines, such as TNF-α, Interleukin-6, Interleukin-18, MCP-1 and resistin is also typical of obese individuals. Obese adipose tissue is infiltrated by cells of monocyte origin producing such peptides 20 . This suggests that the conditions leading to enhanced production and activity of cytokines and chemokines (e.g. liver steatosis or obesity) are associated with low levels of adiponectin. However, the very opposite was recorded in our group of alcohol drinkers.
These findings lead us to the hypothesis that alcohol blocks the inhibitory effect of one or more anti-inflammatory factors (e.g.TNF-α) on adiponectin expression and secretion.
Extensive literature documents that chronic alcohol consumption in humans is related to enhanced insulin sensitivity. Many prospective studies proved have shown regular alcohol intake (so-called moderate drinking) is associated with augmented type 2 diabetes and cardiovascular mortality [40] [41] [42] [43] [44] . We found three experimental studies dealing with a direct impact of chronic alcohol abuse on insulin sensitivity. One of them reported a significant increase in insulin sensitivity after moderate alcohol intake in 51 postmenopausal women 44 , two other studies proved that alcohol had no significant effect on the parameters of insulin sensitivity 12, [42] [43] . The absence of an effect of chronic alcohol intake on insulin sensitivity in these studies might be due to an insufficient daily alcohol dose, short follow-up and many other factors.
A recent study employing healthy volunteers 20 revealed that regular alcohol intake did not only lead to a decrease but to an increase of AN concentrations and enhanced insulin sensitivity (by 11% after a 4-week consumption of 40 g alcohol/day). TNF-α levels did not change significantly due to drinking. This makes us conclude that similar TNF-α levels in both drinkers and non-drinkers lead to attenuated inhibition of adiponectin expression and/or secretion in drinkers and, subsequently, to higher adiponectin levels measured in circulation.
If alcohol intake results in reduction of the inhibitory effect of TNF-α on adiponectin expression and/or secretion, it may be speculated that alcohol also eliminates or blocks other effects of TNF-α which are causal or supportive on the emergence and propagation of metabolic syndrome and atherosclerosis.
To clarify all these relations, extensive experiments should be carried out, particularly at the molecular level. 
